LAVAL, QC, Oct. 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that James R. Howard-Tripp, Chief Executive Officer of the Company, will present at the CIBC World Markets 18th Annual Healthcare Conference in New York City on Monday, November 5, 2007 at 3:40 p.m. ET.
Interested parties may access the live webcast for this presentation by visiting the "Events" section of the homepage of the Company's website at http://www.labopharm.com. Please connect at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to join the webcast. An audio archive of the presentation will be available for 30 days.
About the CIBC World Markets 18th Annual Healthcare Conference
The CIBC World Markets 18th Annual Healthcare Conference will feature a core group of public and private companies who are pioneering the pharmaceutical, biotechnology, medical device, healthcare facility, healthcare technology and distribution, provider and service industries. Presentations will address topical issues such as Medicare and Medicaid reform, generic drug regulation, development of new blockbuster pharmaceutical and biotechnology products, product safety and patent issues, cross-border reimportation, Food and Drug Administration policy, managed care, and a comprehensive look at the current M&A environment.
About Labopharm Inc.
Labopharm is an emerging leader in optimizing the performance of
existing small molecule drugs using its proprietary controlled-release
technologies. The Company's lead product, a unique once-daily formulation
of tramadol, is being commercially launched in key markets globally. The
Company has a robust pipeline of follow-on products in both pre-clinical
and clinical development. Labopharm's vision is to become a fully
integrated, international, specialty pharmaceutical company with the
|SOURCE Labopharm Inc.|
Copyright©2007 PR Newswire.
All rights reserved